Scarica l'app Stockscreener
3.675
31.49%
0.865
Dopo l'orario di chiusura:
3.69
0.015
+0.41%
Larimar Therapeutics Inc Borsa (LRMR) Ultime notizie
Biotech and Big Tech Drive the Morning Narrative - Investing News Network
Tuesday Sector Leaders: Biotechnology, Semiconductors - Nasdaq
Larimar Therapeutics (LRMR) Surges On FDA Breakthrough Therapy Designation - Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
Larimar Soars After FDA Grants Breakthrough Therapy Status To Friedreich's Ataxia Candidate - Nasdaq
Larimar Therapeutics Stock Surges Following Impressive Financial Indicators - StocksToTrade
Larimar Therapeutics jumps on FDA Breakthrough Therapy Designation for nomlabofusp - Quiver Quantitative
Larimar Therapeutics stock surges on FDA breakthrough status By Investing.com - Investing.com South Africa
Larimar Therapeutics stock surges on FDA breakthrough status - Investing.com UK
Larimar Therapeutics’ Recent Stock Trends and Financial Insights - timothysykes.com
Larimar Therapeutics (LRMR) Surges on FDA Breakthrough Designati - GuruFocus
Why Did Larimar Therapeutics’ Stock Surge Over 30% Pre-Market Today? - Stocktwits
Larimar Therapeutics' Friedreich's Ataxia Therapy Receives FDA Breakthrough Status; Shares Rise - marketscreener.com
Larimar Therapeutics shares surged 35.6% in pre-market trading after the company announced that its treatment for a neurological disease had received “Breakthrough Therapy” designation from the U.S. Food and Drug Administration (FDA). - Bitget
Larimar stock surges on FDA breakthrough status (LRMR:NASDAQ) - Seeking Alpha
FDA Grants Breakthrough Therapy Status to Larimar’s Nomlabofusp - TipRanks
Larimar Therapeutics announces FDA Breakthrough Therapy Designation for nomlabofusp - marketscreener.com
Larimar Therapeutics wins FDA Breakthrough Therapy Designation for nomlabofusp; BLA on track for June 2026 - TradingView
Larimar Therapeutics Announces FDA Breakthrough Therapy - GlobeNewswire
IPO Launch: Can Larimar Therapeutics Inc beat the S P 500July 2025 Breakouts & Fast Moving Stock Trade Plans - baoquankhu1.vn
Forecast Cut: Is Larimar Therapeutics Inc being accumulated by smart moneyJuly 2025 Weekly Recap & Short-Term High Return Ideas - baoquankhu1.vn
Is Larimar Therapeutics Inc. impacted by rising ratesCEO Change & Detailed Earnings Play Strategies - mfd.ru
Does Larimar Therapeutics Inc. have consistent dividend growthDollar Strength & Daily Entry Point Trade Alerts - mfd.ru
Investor Mood: Is Larimar Therapeutics Incs growth already priced in2025 Market Trends & Free Expert Verified Stock Movement Alerts - baoquankhu1.vn
Is Larimar Therapeutics Inc. being accumulated by smart moneyQuarterly Portfolio Summary & Verified Technical Trade Signals - mfd.ru
Does Larimar Therapeutics Inc. have a sustainable dividendWeekly Investment Report & Smart Investment Allocation Insights - mfd.ru
Larimar Therapeutics, Inc. (NASDAQ:LRMR) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Gap Down: Will Larimar Therapeutics Inc benefit from geopolitical trendsJuly 2025 Drop Watch & Consistent Return Strategy Ideas - baoquankhu1.vn
Guidance Update: Does Larimar Therapeutics Inc have consistent dividend growthJuly 2025 Setups & Free AI Powered Buy and Sell Recommendations - baoquankhu1.vn
Geopolitics Watch: Is Larimar Therapeutics Inc. being accumulated by smart money2025 Price Momentum & AI Powered Buy/Sell Recommendations - baoquankhu1.vn
Portfolio Update: Is Smith Douglas Homes Corp a cyclical or defensive stockQuarterly Risk Review & Verified Short-Term Trading Plans - baoquankhu1.vn
Larimar Therapeutics executes strategic stock exchange agreement - MSN
Larimar’s Pediatric Friedreich’s Ataxia Trial Termination: What Investors Should Know - TipRanks
Friedreich's Ataxia Pipeline 2025: FDA Approvals and Clinical - openPR.com
AIGH Capital Management LLC Takes $3.23 Million Position in Larimar Therapeutics, Inc. $LRMR - MarketBeat
We Think Larimar Therapeutics (NASDAQ:LRMR) Needs To Drive Business Growth Carefully - Sahm
Head-To-Head Survey: Oncology Pharma (OTCMKTS:ONPH) vs. Larimar Therapeutics (NASDAQ:LRMR) - Defense World
Larimar Therapeutics, Inc. (NASDAQ:LRMR) Receives Average Rating of “Moderate Buy” from Analysts - Defense World
Larimar Therapeutics, Inc. (NASDAQ:LRMR) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Larimar Therapeutics: The Market Is Mispricing A Potential Standard Of Care (NASDAQ:LRMR) - Seeking Alpha
Aug Gainers: What risks investors should watch in Larimar Therapeutics Inc stockQuarterly Profit Summary & Low Risk Entry Point Guides - Bộ Nội Vụ
Published on: 2026-01-14 08:49:57 - Bộ Nội Vụ
Death Cross: How Larimar Therapeutics Inc stock performs during Fed tightening cyclesM&A Rumor & Risk Adjusted Buy and Sell Alerts - Bộ Nội Vụ
Published on: 2026-01-13 20:02:33 - Bộ Nội Vụ
Aug Intraday: Will Larimar Therapeutics Inc. stock outperform value stocks2025 Technical Patterns & Risk Adjusted Buy/Sell Alerts - Bộ Nội Vụ
Published on: 2026-01-13 12:38:02 - moha.gov.vn
Volatility Watch: Does Larimar Therapeutics Inc have a sustainable dividendTrade Risk Assessment & AI Forecast Swing Trade Picks - baoquankhu1.vn
Will Larimar Therapeutics Inc. stock outperform value stocksTrade Volume Summary & Pattern Based Trade Signal System - ulpravda.ru
Contact | Statesman-ExaminerLarimar Therapeutics, Inc.Common Stock (Nasdaq:LRMR) Detailed Stock Data - FinancialContent
Why Larimar Therapeutics Inc. stock remains resilientRate Cut & AI Powered Market Entry Strategies - Улправда
Larimar Therapeutics Advances Friedreich’s Ataxia Program with New Publications on Nomlabofusp Data - MSN
How Larimar Therapeutics Inc. (ZA71) stock trades after rate cutsMarket Volume Report & Low Risk Entry Point Tips - ulpravda.ru
Will Larimar Therapeutics Inc. (ZA71) stock see valuation expansionWeekly Gains Summary & Weekly Watchlist for Hot Stocks - Улправда
Why Larimar Therapeutics Inc. (ZA71) stock could outperform next yearPortfolio Value Report & Risk Adjusted Buy and Sell Alerts - Улправда
How Larimar Therapeutics Inc. (ZA71) stock correlates with oil marketsRisk Mitigation Techniques & Affordable Market Strategies - ulpravda.ru
Larimar Therapeutics (NASDAQ:LRMR) Raised to "Strong-Buy" at Leerink Partnrs - MarketBeat
How buybacks impact Larimar Therapeutics Inc. stock value2026 world cup usa national team third place match young talents high defensive line group prediction breakdown - Улправда
Leerink Partners assumes coverage on Larimar Therapeutics stock with Outperform rating - Investing.com Canada
Short Interest in Larimar Therapeutics, Inc. (NASDAQ:LRMR) Decreases By 19.2% - MarketBeat
Why Larimar Therapeutics Inc. stock could rally in 2025Quarterly Portfolio Summary & Safe Entry Trade Reports - moha.gov.vn
Comparing Altimmune (NASDAQ:ALT) & Larimar Therapeutics (NASDAQ:LRMR) - Defense World
Larimar heads to JPMorgan as rare disease program draws investor attention - MSN
Larimar Heads to JPMorgan as Rare Disease Program Draws Investor Attention - MyChesCo
Larimar Therapeutics, Inc. (NASDAQ:LRMR) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
Should I hold or sell Larimar Therapeutics Inc. stock in 20252025 Sector Review & Smart Money Movement Tracker - Улправда
How institutional buying supports Larimar Therapeutics Inc. stockJuly 2025 Update & Reliable Intraday Trade Plans - Улправда
0.29%
0.15%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):